During the past decade, Gynecologic Oncology of West Michigan PLLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 7 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gynecologic Oncology of West Michigan PLLC" #1 sponsor was "Gynecologic Oncology Group" with 4 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Celgene" with 1 trials sponsored, "MEI Pharma, Inc." with 1 trials sponsored and "Precision Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gynecologic Oncology of West Michigan PLLC" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Gynecologic Oncology Group" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gynecologic Oncology of West Michigan PLLC" are "Stage IV Ovarian Cancer" (4 trials), "Fallopian Tube Cancer" (3 trials), "Stage IIIA Fallopian Tube Cancer" (3 trials), "Stage IIIA Ovarian Cancer" (3 trials) and "Stage IIIA Primary Peritoneal Cancer" (3 trials). Many other conditions were trialed in "Gynecologic Oncology of West Michigan PLLC" in a lesser frequency.

Most popular intervention types in "Gynecologic Oncology of West Michigan PLLC" are "Drug" (8 trials), "Other" (5 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gynecologic Oncology of West Michigan PLLC" are 11 trials for "Female" genders.

Currently, there are NaN active trials in "Gynecologic Oncology of West Michigan PLLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Gynecologic Oncology of West Michigan PLLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Gynecologic Oncology of West Michigan PLLC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".